Gilead and Merck ink collaboration agreement for Keytruda/Trodelvy breast cancer study
For this year Gilead Sciences 's (located in Foster City) revenue will be around 26.5 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2021's revenue of 24.69 billion USD.
Historical revenues and results Gilead Sciences plus estimates 2021
The analysts expect for 2021 a net profit of 10.24 billion USD. According to most of the analysts the company will have a profit per share for this book year of 8.11 USD. Based on this the price/earnings-ratio is 8.29.
Huge dividend Gilead Sciences
Per share the analysts expect a dividend of 2.77 USD per share. Thus the dividend yield equals 4.12 percent. The average dividend yield of the biotech companies equals an attractive2.64 percent.Based on the current number of shares Gilead Sciences 's market capitalization equals 85.08 billion USD. 15
On Monday the stock closed at 67.2 USD.Historical stock prices Gilead Sciences period 2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
